MGI-Tech EU

Technology

News & Events

Resources

Products

Applications

About MGI

See Events

Search site information

Aug 27, 2024

New Strain of Mpox Emerges: MGI Tech’s Pathogen Sequencing Solutions at the Forefront

WHO declared the mpox outbreak a global health emergency. MGI's advanced sequencing tools help rapidly identify and trace the virus, supporting global public health efforts in controlling the spread of the new mpox strain.

NGS

WHO

South Africa is advancing HIV research using MGI’s sequencing tools to study "HIV elite controllers" - A rare group of individuals whose immune systems can suppress infection. Scientists from the SAMRC and UKZN are revealing the answer to the natural control of HIV infection leading to new therapies and improved health outcomes.

Jul 18, 2024

Elite Controllers: Do their genomes hold the key to curing HIV?

MGI Tech and Predica Diagnostics Team Up for Precision RNA Sequencing in Oncology

Jul 11, 2024

MGI Tech & Predica Diagnostics Team Up for Precision RNA Sequencing in Oncology

Two Sequencing Packages Targeting HIV and Mycobacterium Tuberculosis to Combat Infectious Diseases

Jul 3, 2024

Two Sequencing Packages Targeting HIV & Mycobacterium Tuberculosis to Combat Infectious Diseases

Jun 17, 2024

MGI Tech and SeqOne Partner to Advance End-to-end Genomic Analysis

Jun 3, 2024

MGI Tech Unveils New European Headquarters in Berlin, Germany

Jun 3, 2024

MGI Shares New Data on Core DNEBSEQ Technology and Showcases Latest Sequencing Innovations at ESHG 2024

Jul 18, 2024

Elite Controllers: Do their genomes hold the key to curing HIV?

Jul 11, 2024

MGI Tech & Predica Diagnostics Team Up for Precision RNA Sequencing in Oncology

Jul 3, 2024

Two Sequencing Packages Targeting HIV & Mycobacterium Tuberculosis to Combat Infectious Diseases

Jun 17, 2024

MGI Tech and SeqOne Partner to Advance End-to-end Genomic Analysis

All News

MGI Showcases Life Science Excellence at ESCMID 2024 with DNBSEQ-E25 and ABL Diagnostics Partnership

Sequencing

Apr 27, 2024

MGI Showcases Life Science Excellence at ESCMID Global 2024 with Latest DNBSEQ-E25 Sequencer and New Partnership with ABL Diagnostics

MGI debuts DNBSEQ-E25, a portable sequencer, and announces collaboration with ABL Diagnostics for microbiology genotyping at ESCMID Global 2024.

Elevating Precision Health: MGI Tech and Eurofins Genomics Unite with DNBSEQ-T20×2 Sequencer

Genomic Sequencing

Mar 4, 2024

Elevating Precision Health: MGI Tech and Eurofins Genomics Unite with DNBSEQ-T20×2 Sequencer

MGI Tech partners with Eurofins Genomics Europe Genotyping A/S, securing the first European order of the DNBSEQ-T20×2 ultra-high throughput sequencer, advancing large-scale genomic projects.

Exciting Partnership Announcement: MGI and Lexogen Collaborate to Validate QuantSeq and CORALL Libraries on DNBSEQ™ Technology

RNA-Seq

Mar 3, 2024

Exciting Partnership Announcement: MGI and Lexogen Collaborate to Validate QuantSeq and CORALL Libraries on DNBSEQ™ Technology

Exciting news! Lexogen’s QuantSeq and CORALL kits are now validated for MGI sequencers. With the MGIEasy Universal Library Conversion Kit and DNBSEQTM chemistry, experience unmatched RNA sequencing efficiency and accuracy.

DNA Methylation

Nov 10, 2023

Latvia MGI Tech SIA Advances DNA Methylation Research with Significant European Funding

Latvia MGI Tech SIA advances DNA methylation research with significant European funding, achieving groundbreaking progress in biotechnology and innovation.

Globee Awards

Jul 10, 2023

MGI's DNBSEQ-T20*x2 Wins 2023 Globee® Awards for Medical Equipment

Explore MGI's latest achievement as its DNBSEQ-T20×2 gene sequencing platform wins the prestigious Globee® for Medical Equipment in the 15th Annual 2023 Golden Bridge Business and Innovation Awards®.

Unveiling MGI's Groundbreaking Innovations at the ESHG Conference in Glasgow

RNA SEQUENCING

Jun 14, 2023

Unveiling MGI's Groundbreaking Innovations at the ESHG Conference in Glasgow

MGI innovations and partnerships unveiled at the ESHG Conference in Glasgow. Explore MGI's advancements in sequencing and automation, its commitment to revolutionizing genomics, and its strategic partnership with Alithea Genomics in RNA sequencing.

MGI-Tech

Jun 3, 2024

MGI Tech Unveils New European Headquarters in Berlin, Germany

MGI opens its new European headquarters in Berlin, featuring advanced labs, a Customer Experience Center, and showcasing the latest life science innovations and multi-omics tools.

ESHG Conference

Jun 3, 2024

MGI Shares New Data on Core DNEBSEQ Technology and Showcases Latest Sequencing Innovations at ESHG 2024

MGI Tech unveils Q40 quality data for DNBSEQ with StandardMPS 2.0 Chemistry and launches DNBelab C-TaiM 4 Single-Cell Droplet Generator at ESHG 2024, showcasing major innovations.

Sequencing

Apr 27, 2024

MGI Showcases Life Science Excellence at ESCMID Global 2024 with Latest DNBSEQ-E25 Sequencer and New Partnership with ABL Diagnostics

MGI debuts DNBSEQ-E25, a portable sequencer, and announces collaboration with ABL Diagnostics for microbiology genotyping at ESCMID Global 2024.

Genomic Sequencing

Mar 4, 2024

Elevating Precision Health: MGI Tech and Eurofins Genomics Unite with DNBSEQ-T20×2 Sequencer

MGI Tech partners with Eurofins Genomics Europe Genotyping A/S, securing the first European order of the DNBSEQ-T20×2 ultra-high throughput sequencer, advancing large-scale genomic projects.

RNA-Seq

Mar 3, 2024

Exciting Partnership Announcement: MGI and Lexogen Collaborate to Validate QuantSeq and CORALL Libraries on DNBSEQ™ Technology

DNA Methylation

Nov 10, 2023

Latvia MGI Tech SIA Advances DNA Methylation Research with Significant European Funding

Latvia MGI Tech SIA advances DNA methylation research with significant European funding, achieving groundbreaking progress in biotechnology and innovation.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Resources

Products

Bioinformatic Products

Novel Products

About MGI

Who we are